We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$39.3B
1-Year Est. Return
27.96%
This Fund
S&P 500
This Quarter
Est. Return
+13.03%
1 Year Est. Return
+27.96%
3 Year Est. Return
+58.37%
5 Year Est. Return
+80.22%
10 Year Est. Return
+439.89%
AUM
$39.3B
AUM Growth
+$3.7B
(+10%)
Cap. Flow
+$2.27B
Cap. Flow
% of AUM
5.78%
Top 10 Holdings %
Top 10 Hldgs %
11.24%
Holding
2,749
New
386
Increased
1,048
Reduced
996
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$393M |
| 2 |
AngloGold Ashanti
AU
|
+$356M |
| 3 |
General Dynamics
GD
|
+$348M |
| 4 |
NVIDIA
NVDA
|
+$202M |
| 5 |
Kroger
KR
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$441M |
| 2 |
CVS Health
CVS
|
+$424M |
| 3 |
United Parcel Service
UPS
|
+$359M |
| 4 |
Devon Energy
DVN
|
+$243M |
| 5 |
Target
TGT
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Miscellaneous | 16.91% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNVR
1201
Pacer Swan SOS Moderate (November) ETF
MNVR
$1.67M
| $133K | ﹤0.01% |
+4,063
| New | +$131K |
|
|
MDCR
1202
Pacer Swan SOS Moderate December ETF
MDCR
$1.65M
| $133K | ﹤0.01% |
+4,110
| New | +$132K |
|
|
MJUN
1203
Pacer Swan SOS Moderate June ETF
MJUN
$1.65M
| $133K | ﹤0.01% |
+4,110
| New | +$132K |
|
|
MMAR
1204
Pacer Swan SOS Moderate March ETF
MMAR
$1.65M
| $133K | ﹤0.01% |
+4,110
| New | +$132K |
|
|
MAUG
1205
Pacer Swan SOS Moderate (August) ETF
MAUG
$1.67M
| $132K | ﹤0.01% |
+4,073
| New | +$131K |
|
|
MSEP
1206
Pacer Swan SOS Moderate September ETF
MSEP
$1.65M
| $132K | ﹤0.01% |
+4,107
| New | +$132K |
|
1207
Cellebrite
CLBT
$2.88B
| $127K | ﹤0.01% |
8,702
+1,095
| +14% | +$14.5K |
|
1208
Merit Medical Systems
MMSI
$5.35B
| $127K | ﹤0.01% |
1,831
+191
| +12% | +$12.6K |
|
1209
Adtran
ADTN
$579M
| $124K | ﹤0.01% |
+8,951
| New | +$140K |
|
1210
GlobalFoundries
GFS
$24.8B
| $124K | ﹤0.01% |
1,509
-778
| -34% | -$54.4K |
|
1211
Q2 Holdings
QTWO
$3.87B
| $123K | ﹤0.01% |
2,550
+894
| +54% | +$42.4K |
|
1212
ADMA Biologics
ADMA
$2.15B
| $122K | ﹤0.01% |
+14,528
| New | +$132K |
|
|
LIF
1213
Life360
LIF
$3.6B
| $122K | ﹤0.01% |
2,201
+330
| +18% | +$14.7K |
|
1214
Gilat Satellite Networks
GILT
$780M
| $110K | ﹤0.01% |
+8,299
| New | +$136K |
|
|
WAY
1215
Waystar Holding Corp
WAY
$4.81B
| $109K | ﹤0.01% |
5,325
+1,716
| +48% | +$36.1K |
|
1216
Sportradar
SRAD
$3.82B
| $88K | ﹤0.01% |
5,900
-316
| -5% | -$4.6K |
|
1217
Transmedics
TMDX
$3.12B
| $85K | ﹤0.01% |
1,280
-1,111
| -46% | -$94K |
|
1218
Grab
GRAB
$14B
| $83K | ﹤0.01% |
21,932
-1,095
| -5% | -$3.99K |
|
1219
Genius Sports
GENI
$2B
| $79K | ﹤0.01% |
13,088
-2,182
| -14% | -$11.3K |
|
1220
JFrog
FROG
$10.8B
| $78K | ﹤0.01% |
862
+33
| +4% | +$2.14K |
|
1221
Enova International
ENVA
$5.74B
| $76K | ﹤0.01% |
315
-97
| -24% | -$16.7K |
|
|
APGE
1222
DELISTED
Apogee Therapeutics
APGE
| $74K | ﹤0.01% |
+557
| New | +$50.2K |
|
1223
Jackson Financial
JXN
$9.52B
| $70K | ﹤0.01% |
679
-174
| -20% | -$18.9K |
|
1224
Twist Bioscience
TWST
$8.21B
| $70K | ﹤0.01% |
+680
| New | +$44.2K |
|
|
ORKA
1225
Oruka Therapeutics
ORKA
$6.13B
| $69K | ﹤0.01% |
+720
| New | +$48K |
|
Similar funds
PPF
CS
Pacer Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Pacer Advisors held 2,749 positions worth $39.3B, up 10% from $35.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Pacer Advisors deployed $2.27B of net new capital in Q2 2026, opening 386 new positions and adding to 1,048 existing holdings. Its largest new stake was AngloGold Ashanti: 3,744,168 shares worth $303M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was ConocoPhillips, an estimated $441M trimmed.
- Pacer Advisors's largest Q2 2026 buy was AngloGold Ashanti: 3,744,168 shares worth $303M.
- Pacer Advisors added most to Lowe's Companies in Q2 2026, an estimated $393M increase.
- Pacer Advisors's biggest Q2 2026 reduction was ConocoPhillips, cutting an estimated $441M.
- Pacer Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 11% of its $39.3B portfolio in Q2 2026.
- Pacer Advisors opened 386 new positions and closed 125 in Q2 2026.
- Pacer Advisors's portfolio value rose 10% quarter-over-quarter to $39.3B.
Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.